trending Market Intelligence /marketintelligence/en/news-insights/trending/IdPL9HRMh4TYTsgZye-iag2 content esgSubNav
In This List

CytoSorbents chief medical officer retires; replacement named

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


CytoSorbents chief medical officer retires; replacement named

Cytosorbents Corp. said its chief medical officer Robert Bartlett has retired from his post, but will stay with the company as a consultant and as co-chair of the cardiac surgery advisory board.

Eric Mortensen, who was previously vice president and therapeutic area clinical head for inflammation and immunology at Pfizer Inc., will replace Bartlett as chief medical officer.